These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28956494)

  • 1. In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates.
    Bogdan M; Drenjancevic D; Harsanji Drenjancevic I; Bedenic B; Zujic Atalic V; Talapko J; Vukovic D
    J Chemother; 2018 Feb; 30(1):16-24. PubMed ID: 28956494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
    Shafiee F; Naji Esfahani SS; Hakamifard A; Soltani R
    Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
    Kaliterna V; Kaliterna M; Hrenović J; Barišić Z; Tonkić M; Goic-Barisic I
    Infect Dis (Lond); 2015; 47(12):902-7. PubMed ID: 26365683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.
    Kim HA; Ryu SY; Seo I; Suh SI; Suh MH; Baek WK
    Microb Drug Resist; 2015 Aug; 21(4):452-7. PubMed ID: 25714496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures.
    Wang Y; Bao W; Guo N; Chen H; Cheng W; Jin K; Shen F; Xu J; Zhang Q; Wang C; An Y; Zhang K; Wang F; Yu L
    World J Microbiol Biotechnol; 2014 Dec; 30(12):3015-25. PubMed ID: 25298216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sub-Minimum Inhibitory Concentrations of Imipenem and Colistin on Expression of Biofilm-Specific Antibiotic Resistance and Virulence Genes in
    Shenkutie AM; Zhang J; Yao M; Asrat D; Chow FWN; Leung PHM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex].
    Villar HE; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of imipenem and sulbactam on sessile cells of Acinetobacter baumannii growing in biofilm.
    Vidal R; Dominguez M; Urrutia H; Bello H; Garcia A; Gonzalez G; Zemelman R
    Microbios; 1997; 91(367):79-87. PubMed ID: 9467922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of rifampicin alone and in combination with imipenem against multidrug-resistant Acinetobacter baumannii harboring the blaOXA-72 resistance gene.
    Majewski P; Wieczorek P; Ojdana D; Sacha PT; Wieczorek A; Tryniszewska EA
    Scand J Infect Dis; 2014 Apr; 46(4):260-4. PubMed ID: 24447252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.